NCT00463762撤回不适用
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections In Slovakia. An Open, Prospective, Non-Comparative Study.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Pfizer
研究概览
简要总结
The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdominal and hepatobiliary infections in Slovakia.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patient of age 18 years or older.
- •Patient with intraabdominal/hepatobiliary infection.?
排除标准
- •Patients with known hypersensitivity to penicillins, cephalosporins, cefoperazone or to sulbactam.
研究者
相似试验
已完成
不适用
Ceprotin Treatment RegistryProtein C DeficiencyNCT01127529Baxalta now part of Shire43
Unknown
不适用
Multidrug Resistant Shigella Infection in BangladeshDiarrheaShigellaNCT03778125University of Virginia2,000
Unknown
不适用
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal CancerNeoplasms, Therapy-AssociatedNCT02523495Huazhong University of Science and Technology120
已完成
2 期
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-TransplantHepatocellular CarcinomaHepatitis CNCT01559844Gilead Sciences61
招募中
不适用
Therapeutic Recommendations for NephroblastomaNephroblastomaNCT04423484French Africa Pediatric Oncology Group1,000